[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100447158":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":18,"locations":27,"responsibleParty":45,"collaborators":10,"id":47,"slug":10,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":48,"sex":53,"minAge":10,"maxAge":10,"enrollmentInfo":54,"targetDuration":10,"studyType":57,"phases":10,"briefSummary":58,"conditions":59,"keywords":61,"overallStatus":30,"whyStopped":10,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"Rigshospitalet, Denmark","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Anoctaminopathies",null,"Anoctaminopathies including Limb Girdle Muscular Dystrophy R12, Miyoshi distal Muscular Dystrophy type 3 and asymptomatic hyperCKemia",[13],"Other: No intervention",[15],{"type":6,"name":16,"description":16,"armGroupLabels":17,"otherNames":10},"No intervention",[9],[19,24],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},"Nanna S Poulsen, MD","CONTACT","+4535454346","Nanna.scharff.poulsen@regionh.dk",{"name":25,"role":21,"phone":10,"phoneExt":10,"email":26},"John Vissing, MD, DMSc","john.vissing@regionh.dk",[28],{"facility":29,"status":30,"city":31,"state":10,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"Nanna Scharff Poulsen","RECRUITING","Copenhagen","2100","Denmark","DK",{"type":36,"coordinates":37},"Point",[38,39],12.56553,55.67594,{"lat":39,"lon":38},[42,43],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},{"name":20,"role":44,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"type":44,"investigatorFullName":29,"investigatorTitle":46,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Principal investigator","100447158",false,"NCT05102799","MRI-phenotyping of Patients With Pathogenic Anoctamin 5 Variants","ANO5 MRI","Inclusion Criteria:\n\n* Two pathogenic variants in the anoctamin-5 gene\n* T1-weighted MR-images of lower back and leg muscles.\n\nExclusion Criteria:\n\n\\- Concomitant other disorders that also can result in muscular atrophy, i.e. polyneuropathy, other muscle diseases, recent long-term stay in intensive care, among others.","ALL",{"count":55,"type":56},200,"ESTIMATED","OBSERVATIONAL","A large cohort of MRI scans from patients with pathogenic variants in the anoctamin 5 gene will be collected through an international collaboration to better describe muscle involvement.",[60],"Limb Girdle Muscular Dystrophy",[62],"Anoctaminophathies","2025-04-02",{"date":65,"type":66},"2025-04-06","ACTUAL",{"date":68,"type":66},"2021-04-01",{"date":70,"type":56},"2026-08-01",{"name":5,"class":6},1]